Phase IIb study of Botulinum-toxin-A in Plantar-fasciitis.
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Plantar fasciitis
- Focus Therapeutic Use
- 04 Dec 2018 According to a Revance Therapeutics media release, the company plans to announce first patient dosing before year-end 2018.
- 09 Jan 2018 New trial record
- 04 Jan 2018 According to a Revance Therapeutics media release, company expects to initiate this trial in the second half of 2018.